Canada - English - Health Canada

apotex inc - sitagliptin (sitagliptin phosphate monohydrate); metformin hydrochloride - tablet (extended-release) - 100mg; 1000mg - sitagliptin (sitagliptin phosphate monohydrate) 100mg; metformin hydrochloride 1000mg

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - tablets - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 500 mg - metformin - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - tablets - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 850 mg - metformin - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

Canada - English - Health Canada

pharmascience inc - sitagliptin (sitagliptin phosphate monohydrate) - tablet - 50mg - sitagliptin (sitagliptin phosphate monohydrate) 50mg

Canada - English - Health Canada

pharmascience inc - sitagliptin (sitagliptin phosphate monohydrate) - tablet - 100mg - sitagliptin (sitagliptin phosphate monohydrate) 100mg

Canada - English - Health Canada

pharmascience inc - sitagliptin (sitagliptin phosphate monohydrate) - tablet - 25mg - sitagliptin (sitagliptin phosphate monohydrate) 25mg

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - sitagliptin phosphate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - sitagliptin phosphate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - sitagliptin phosphate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - sitagliptin fumarate, quantity: 128.497 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; crospovidone; hydrogenated castor oil; glycerol dibehenate; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red - sitagliptin sun (sitagliptin fumarate) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as: - monotherapy when metformin is considered inappropriate due to intolerance; or - in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].